Tavo Biotherapeutics

Dorchester, United States

Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.

Jun 2026

Series A

Biotechnology Health Care Therapeutics

Top Investors

Polaris PartnersTau VenturesPureos Bioventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tavo Biotherapeutics

Who are Tavo Biotherapeutics's investors?

Tavo Biotherapeutics's investors include Polaris Partners, Tau Ventures, Pureos Bioventures.

Where is Tavo Biotherapeutics headquartered?

Tavo Biotherapeutics is headquartered in Dorchester, United States.

What does Tavo Biotherapeutics do?

Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.

What stage is Tavo Biotherapeutics at?

Tavo Biotherapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 2, 2026.

MLA

"Tavo Biotherapeutics — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/tavo-biotherapeutics. Accessed June 30, 2026.

APA

VCBacked. (2026). Tavo Biotherapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/tavo-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Tavo Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavo-biotherapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 2, 2026.

Similar Companies in Biotechnology